July 2020
Volume 61, Issue 9
Free
ARVO Imaging in the Eye Conference Abstract  |   July 2020
Author Affiliations & Notes
  • Danilo Andrade De Jesus
    Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Sander Wooning
    Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Daniël Luttikhuizen
    Department of Epidemiology, Erasmus MC, Rotterdam, Netherlands
  • Muhammad Shirazi
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  • Michael Pircher
    Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria
  • Caroline Klaver
    Department of Epidemiology, Erasmus MC, Rotterdam, Netherlands
    Department of Ophthalmology, Erasmus MC, Rotterdam, Netherlands
  • Johannes R. Vingerling
    Department of Ophthalmology, Erasmus MC, Rotterdam, Netherlands
  • Stefan Klein
    Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Theo van Walsum
    Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Luisa Sanchez Brea
    Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, Netherlands
  • Footnotes
    Commercial Relationships   Danilo Andrade De Jesus, None; Sander Wooning, None; Daniël Luttikhuizen, None; Muhammad Shirazi, None; Michael Pircher, None; Caroline Klaver, None; Johannes R. Vingerling, None; Stefan Klein, None; Theo van Walsum, None; Luisa Sanchez Brea, None
  • Footnotes
    Support  Horizon 2020 research and innovation programme (Grant No. 780989: Multi-modal, multi-scale retinal imaging project).
Investigative Ophthalmology & Visual Science July 2020, Vol.61, PB00104. doi:
Abstract

Purpose : Drusen deposits that form between the retinal pigment epithelium (RPE) and Bruch's membrane (BM) are a significant risk factor for age-related macular degeneration (AMD). In this work, a novel way of automatically segmenting the RPE-BM complex in OCT images from multiple devices using a convolutional neural network is proposed.

Methods : A total of 15744 B-scans (Bioptigen SD-OCT, NC, USA) from 269 early AMD patients and 115 normal subjects, selected from a publicly available dataset, were used in this study (split on subject level in 70% train, 10% validation and 20% test). For each B-scan, the inner limiting membrane (ILM), RPE, and BM have been manually segmented (Fig. 1). A convolutional neural network (U-Net) with generalized Dice loss function was trained to segment the three retinal layers. Data augmentation was used, including geometric and intensity transformations. Postprocessing was applied to the output of the U-Net, removing the small connected components and using a minimal cost path function to ensure connectivity within each layer. To test the segmentation algorithm, OCT data from three other devices (3D-2000 SD-OCT, Topcon Corporation, Japan; Spectralis SD-OCT, Heidelberg Engineering, Germany; MERLIN SS-OCT, Imagine Eyes, France) were used. The segmentation performance was assessed using Dice score and visual inspection by an experienced AMD specialist.

Results : The Dice score for the Bioptigen test set was 0.97. Visual assessment confirmed that the predictions of the model in the B-scans from the four different devices followed the retinal layers accurately. The predicted RPE-BM complex was color coded displayed as a function of the RPE-BM distance (abnormal thickness indicated in red), thus allowing the location and analysis of the drusen deposits (Fig. 2).

Conclusions : The proposed approach is a first step towards the automation of soft drusen quantification and follow up, as it enables the automatic assessment of the RPE-BM complex in healthy and AMD data from four different OCT devices.

This is a 2020 Imaging in the Eye Conference abstract.

 

B-scan from the Bioptigen test set with the manually segmented retinal layers (ILM, BM, and RPE) overlayed (A); annotated mask (B); prediction with the RPE-BM complex highlighted (C).

B-scan from the Bioptigen test set with the manually segmented retinal layers (ILM, BM, and RPE) overlayed (A); annotated mask (B); prediction with the RPE-BM complex highlighted (C).

 

Model predictions and highlighted RPE-BM complex on each dataset: Bioptigen (A); Spectralis (B); Topcon (C); MERLIN (D). Different acquisition settings were considered between devices.

Model predictions and highlighted RPE-BM complex on each dataset: Bioptigen (A); Spectralis (B); Topcon (C); MERLIN (D). Different acquisition settings were considered between devices.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×